TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07216001: Role of Omega-DEK in Childhood Apraxia of Speech

Sponsor: Claudia R. Morris · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 34 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$531,200

Rescue Site Savings

+$365,200

Unlock Full NCT07216001 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07216001 Rescue Dossier →